VR Logo

Krebs Biochemicals & Inds. Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

39 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1991

Chairman: R T Ravi

Managing Director: Avinash Ravi

Group: --

Listing: NSE: KREBSBIO, BSE: 524518

Headquarters: Vishakhapatnam, Andhra Pradesh

Website: www.krebsbiochem.com

Key Facts

Market cap: R 165.30 Cr

Revenue (TTM): R 30.37 Cr

Earnings (TTM): R -27.92 Cr

Cash: R 17.32 Cr

Total Debt: R 53.38 Cr

Promoters' ownership: 64.66%

Liquidity: Moderate

52 Week range: R 60.65 - 110.00

Face value: R10.00

Shares outstanding: 1,96,20,586

10 Years Aggregate:

  • CFO: -46.71 Cr
  • EBITDA: -61.24 Cr
  • Net Profit: -127.38 Cr

Stock Performance

Time Period Krebs Biochemicals & Inds. S&P BSE Healthcare S&P BSE Small Cap
YTD5.3117.93-15.54
1 month16.213.294.22
3 months-13.1413.75-15.99
1 Year-6.3917.97-22.54
3 Years-4.654.50-8.90
5 Years0.49-0.111.33
10 Years9.6611.122.98
As on 03-Jun-2020
Year Krebs Biochemicals & Inds. S&P BSE Small Cap S&P BSE Healthcare
2019-24.31-6.85-3.55
2018-22.29-23.41-5.89
201772.3359.640.49
2016-40.481.77-12.88
2015321.476.7615.06
2014153.9469.2447.43
2013-37.74-11.2322.55